Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
Lang
D R
DR
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-7630, USA.
Allos
B M
BM
Blaser
M J
MJ
D002167:Campylobacter / Q000145:classification / Q000276:immunology / Q000472:pathogenicity*; D002169:Campylobacter Infections / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D016123:Campylobacter jejuni / Q000472:pathogenicity; D017048:Health Care Costs; D006801:Humans; D011129:Polyradiculoneuropathy / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology; D011159:Population Surveillance; D012106:Research